Detalhe da pesquisa
1.
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort.
Ann Rheum Dis
; 2024 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38373843
2.
Prevalence, characteristics, and outcome of subclinical vasculitis in polymyalgia rheumatica: a retrospective cohort study.
Rheumatology (Oxford)
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547403
3.
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
Rheumatology (Oxford)
; 2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460548
4.
Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodies.
Ann Rheum Dis
; 82(4): 546-555, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572507
5.
Autoantibodies against the NineTeen complex and U5 RNP in systemic sclerosis.
J Autoimmun
; 139: 103056, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37302272
6.
Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis.
J Autoimmun
; 135: 102988, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634459
7.
Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domains.
Rheumatology (Oxford)
; 2023 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37572295
8.
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies.
Clin Exp Rheumatol
; 40(2): 274-283, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35200123
9.
Phenotypical and Functional Characterization of Neutrophils in Two Pyrin-Associated Auto-inflammatory Diseases.
J Clin Immunol
; 41(5): 1072-1084, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33666778
10.
TET2-Driver and NLRC4-Passenger Variants in Adult-Onset Autoinflammation.
N Engl J Med
; 388(17): 1626-1629, 2023 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099347
11.
Phenotypic analysis of pyrin-associated autoinflammation with neutrophilic dermatosis patients during treatment.
Rheumatology (Oxford)
; 60(11): 5436-5446, 2021 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33693560
12.
The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort.
Rheumatology (Oxford)
; 60(11): 5028-5041, 2021 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580257
13.
Can We Expect Any Effect of Rituximab on Fatigue in Primary Sjögren Syndrome?: A Systematic Review and Critical Appraisal.
J Clin Rheumatol
; 27(8): e510-e515, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804258
14.
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients.
Ann Rheum Dis
; 79(9): 1218-1226, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561607
15.
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial.
Ann Rheum Dis
; 79(5): 618-625, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299845
16.
Anti-TIF1-γ autoantibodies: warning lights of a tumour autoantigen.
Rheumatology (Oxford)
; 59(3): 469-477, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31883334
17.
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual.
Ann Rheum Dis
; 78(12): 1681-1685, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31422354
18.
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.
Ann Rheum Dis
; 78(7): 979-987, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30967395
19.
Detection of anti-eIF2B autoantibodies in systemic sclerosis by immunoprecipitation-mass spectrometry.
Rheumatology (Oxford)
; 62(7): e216-e218, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36715621
20.
Screening for connective tissue disease-associated antibodies by automated immunoassay.
Clin Chem Lab Med
; 56(6): 909-918, 2018 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29306915